About this journal

Aims and scope

Expert Opinion on Pharmacotherapy [ISSN 1465-6566]; [e-ISSN 1744-7666] is a MEDLINE-indexed, international subscription-based journal publishing rigorously peer-reviewed review articles and original papers on newly approved/near to launch compounds mainly of chemical/synthetic origin, providing expert opinion on the likely impact of these new agents on existing pharmacotherapy of specific diseases.

Each article is structured to incorporate the author’s own expert opinion on the impact of the topic on research and clinical practice and the scope for future development.

Expert Opinion on Pharmacotherapy addresses the needs of research and development, regulatory and marketing decision makers in the pharmaceutical industry and decision makers in healthcare provision.

The Editors welcome:

  • Reviews covering new drugs/drug classes for specific diseases, from development Phase III to those that have been available to pharmacopoeia for up to 5 years, and their potential impact on future treatment strategies.
  • Drug Evaluations reviewing the clinical and pharmacological data on a particular drug.
  • Original Research papers reporting the results of clinical investigations on agents that are in Phase III and IV clinical trials and pharmacologically based studies with a strong link to clinical practice.

Once your paper has been assessed for suitability by the Editorial Team, it will then be double-anonymous peer-reviewed by independent, expert referees.

Please note that the journal does not publish case reports, case series, or animal studies. 

Reach an international clinical and medical audience alongside other key option leaders in your field by publishing with Expert Opinion on Pharmacotherapy, part of the Expert Collection brand. 

For any pre-submission enquiries, please contact the Commissioning Editor.

Journal metrics

Usage

  • 427K annual downloads/views

Citation metrics

  • 2.5 (2023) Impact Factor
  • 3.3 (2023) 5 year IF
  • 5.6 (2023) CiteScore (Scopus)
  • Q2 CiteScore Best Quartile
  • 0.747 (2023) SNIP
  • 0.687 (2023) SJR

Speed/acceptance

  • 25 days avg. from submission to first decision
  • 38 days avg. from submission to first post-review decision
  • 7 days avg. from acceptance to online publication
  • 59% acceptance rate

Editorial board

EDITORIAL ADVISORY BOARD

Prof. Wilbert Aronow, Westchester Medical Center, Valhalla, NY, USA

Prof. Maciej Banach, Polish Mothers Memorial Hospital, Lodz, Poland

Dr. Francesco Brigo, Hospital of Merano, Merano-Meran, Italy

Dr. Sara Bringhen, A.O.U. City of Health and Sciences, Turin, Italy

Dr. Leslie Citrome, New York Medical College, Valhalla, NY, USA

Dr. Thomas Ciulla, Midwest Eye Institute, Carmel, IN, USA

Dr. Constantin A Dasanu, University of California San Diego, San Diego, CA, USA

Prof. Stephen N Davis, University of Maryland Medical Center, Baltimore, MD, USA

Prof. Erik de Clercq, Retired, Belgium

Dr. Guillermo Di Girolamo, University of Buenos Aires, Buenos Aires, Argentina

Dr. Sheila A Doggrell, Queensland University of Technology, Brisbane, Australia

Dr. Jaime Esteban, Jiménez Díaz Foundation University Hospital, Madrid, Spain

Prof. Steven Feldman, Wake Forest School of Medicine, Winston-Salem, NC, USA

Prof. Simone Ferrero, IRCCS Ospedale Policlinico San Martino, Genoa, Italy

Prof. Jakub Fichna, University of Lodz, Lodz, Poland

Dr. Robert L Findling, Johns Hopkins University, Baltimore, MD, USA

Prof. Kostas N Fountoulakis, Aristotle University of Thessaloniki, Thessaloniki, Greece

Dr. Daniela Galimberti, University of Milan, Milan, Italy

Dr. Daniele R Giacobbe, University of Genoa, Genoa, Italy

Paul Greenberg, Analysis Group, Inc, Boston, MA, USA

Prof. George Grossberg, St Louis University School of Medicine, St. Louis, MO, USA

Prof. Paul Gurbel, Inova Center for Thrombosis Research and Drug Development, Falls Church, MD, USA

Prof. Nicola Hanania, Baylor College of Medicine, Houston, TX, USA

Prof. Michael G Irwin, University of Hong Kong, Pok Fu Lam, Hong Kong SAR

Prof. Siegfried Kasper, University of Vienna, Vienna, Austria

Prof. Catherine Kelly, University College Dublin, Dublin, Ireland

Prof. Jay Khastgir, Swansea University, Swansea, UK

Prof. Anastasios Konstas, Aristotle University of Thessaloniki, Thessaloniki, Greece

Prof. Sandro La Vignera, University of Catania, Catania, Italy

Dr. Herbert A Kirst, Consultant, Indianapolis, IN, USA

Prof. Ken Lee, Monash University, Subang Jaya, Malaysia

Prof. Gregory Y Lip, University of Liverpool, Liverpool, UK

Dr. Shari Lipner, Weill Cornell Medical College, New York, NY, USA

Prof. Donatella Marazziti, University of Pisa, Pisa, Italy

Prof. Hartmut Lode, Charité – Universitätsmedizin Berlin, Berlin, Germany

Prof. Sharon Marsh, University of Alberta, Edmonton, AB, Canada

Prof. Paolo Martelletti, Sapienza University of Rome, Rome, Italy

Prof. Maria G Matera, University of Campania Luigi Vanvitelli, Campania, Italy

Prof. Dimitri Mikhailidis, University College London, London, UK

Prof. Filippo Montemurro, Istituto di Candiolo, Candiolo, Italy

Dr. Marco Mula, St George's University, London, UK

Prof. Thomas Muller, St Joseph Hospital, Berlin, Germany

Prof. Benoit Mulsant, University of Toronto, Toronto, ON, Canada

Dr. Eduardo Mysler, Organización Médica de Investigación, Buenos Aires, Buenos Aires, Argentina

Dr. Francesco Panza, National Institute of Gastroenterology "Saverio de Bellis", Research Hospital, Bari, Italy

Prof. Athanasios Papatsoris, University of Athens, Athens, Greece

Prof. Petros Perimenis, University Hospital of Patras, Patras, Greece

Prof. Gerald E Piérard, University Hospital of Liège, Liège, Belgium

Prof. Tadusz Robak, Medical University of Lodz, Lodz, Poland

Dr. Massimiliano Ruscica, University of Milan, Milan, Italy

Dr. Emilio Sacco, Catholic University of the Sacred Heart, Milan, Italy

Prof. Ernst R Schwarz, Cedars Sinai Medical Center, Culver City, CA, USA

Dr. Nicholas Short, University of Texas MD Anderson Cancer Center, Houston, TX, USA

Prof. Dave Singh, Medicines Evaluation Unit, Manchester, UK

Prof. Guru Sonpavde, Harvard University, Cambridge, MA, USA

Prof. Carol Stanciu, Institute of Gastroenterology and Hepatology, Iasi, Romania

Dr. Jeffrey Strawn, University of Cincinnati, Cincinnati, OH, USA

Prof. Yoshiya Tanaka, University of Occupational & Environmental Health, Kitakyushu, Japan

Prof. Theoharis Theoharides, Tufts University, Medford, MA, USA

Prof. Brian Tomlinson, The Chinese University of Hong Kong, Hong Kong SAR

Prof. Giuseppe Tonini, University Campus Bio-Medico, Rome, Italy

Prof. Antoni Torres, Clinical and Provincial Hospital of Barcelona, Barcelona, Spain

Prof. Laszlo Vecsei, University of Szeged, Szeged, Hungary

Prof. Uwe Wollina, Städtisches Klinikum Dresden, Dresden, Germany

Prof. Joyce H You, The Chinese University of Hong Kong, Hong Kong SAR

Abstracting and indexing

Expert Opinion on Pharmacotherapy

is included in the following abstracting and indexing services:

Chemical Abstracts (CODEN: EOPHF7); Current Contents®/Clinical Medicine; EMBASE/Excerpta Medica; Index to Scientific Reviews; Index Medicus/Medline; ISI Alerting Services™; Science Citation Index Expanded.

Open access

Expert Opinion on Pharmacotherapy is a hybrid open access journal that is part of our Open Select publishing program, giving you the option to publish open access. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research.

Why choose open access?

  1. Increase the discoverability and readership of your article
  2. Make an impact and reach new readers, not just those with easy access to a research library
  3. Freely share your work with anyone, anywhere
  4. Comply with funding mandates and meet the requirements of your institution, employer or funder
  5. Rigorous peer review for every open access article

Article Publishing Charges (APC)

If you choose to publish open access in this journal you may be asked to pay an Article Publishing Charge (APC). You may be able to publish your article at no cost to yourself or with a reduced APC if your institution or research funder has an open access agreement or membership with Taylor & Francis.

Use our APC finder to calculate your article publishing charge

Advertising information

Would you like to advertise in Expert Opinion on Pharmacotherapy?

Reach an engaged target audience and position your brand alongside authoritative peer-reviewed research by advertising in Expert Opinion on Pharmacotherapy.

Explore advertising solutions

Taylor & Francis make every effort to ensure the accuracy of all the information (the "Content") contained in our publications. However, Taylor & Francis, our agents (including the editor, any member of the editorial team or editorial board, and any guest editors), and our licensors, make no representations or warranties whatsoever as to the accuracy, completeness, or suitability for any purpose of the Content. Any opinions and views expressed in this publication are the opinions and views of the authors, and are not the views of or endorsed by Taylor & Francis. The accuracy of the Content should not be relied upon and should be independently verified with primary sources of information. Taylor & Francis shall not be liable for any losses, actions, claims, proceedings, demands, costs, expenses, damages, and other liabilities whatsoever or howsoever caused arising directly or indirectly in connection with, in relation to, or arising out of the use of the Content. Terms & Conditions of access and use can be found at http://www.tandfonline.com/page/terms-and-conditions .

Ready to submit?

Start a new submission or continue a submission in progress

Go to submission site (link opens in a new window) Instructions for authors